Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 08, 2020

SELL
$34.22 - $76.49 $27,718 - $61,956
-810 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$68.92 - $85.27 $192,838 - $238,585
-2,798 Reduced 77.55%
810 $61,000
Q3 2019

Oct 31, 2019

SELL
$71.74 - $86.35 $11,621 - $13,988
-162 Reduced 4.3%
3,608 $266,000
Q2 2019

Aug 09, 2019

BUY
$66.45 - $97.36 $7,508 - $11,001
113 Added 3.09%
3,770 $271,000
Q1 2019

Apr 24, 2019

BUY
$86.15 - $100.49 $117,767 - $137,369
1,367 Added 59.69%
3,657 $356,000
Q4 2018

Jan 30, 2019

BUY
$84.14 - $125.42 $192,680 - $287,211
2,290 New
2,290 $209,000
Q4 2017

Feb 07, 2018

SELL
$71.8 - $88.21 $52,916 - $65,010
-737 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$60.32 - $70.06 $44,455 - $51,634
737
737 $52,000

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.61B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.